Summary
Twenty-one patients with advanced Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, prednisone) were treated with ABVD (adriamycin, bleomycin, vinblastine, dacarbazine). ABVD induced complete remission in 13 patients (62%) and partial remission in 2 (9.5%). In particular, complete response to ABVD was obtained in 7 of 13 patients who failed to respond to primary MOPP chemotherapy. After six cycles, no further therapy was given to patients in complete remission. At 36 months from starting ABVD, 69.7% of complete responders remain alive and free of disease, with a total survival of 73.4%. In contrast, none of the patients in whom partial response or nonresponse was observed was alive at 18 months. ABVD for six cycles was accompanied by mild and reversible toxicity. The results indicate that there is no cross-resistance between MOPP and ABVD. ABVD appears a simple, effective, and tolerable multiple-drug chemotherapy for use in patients who are resistant to MOPP.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonadonna, G., Uslenghi, C., Zucali, R.: Recent trends in the medical treatment of Hodgkin's disease. Eur. J. Cancer 11, 251 (1975)
Bonadonna, G., Zucali, R., Monfardini, S., De Lena, M., Uslenghi, C.: Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36, 252 (1975)
Bonadonna, G., Zucali, R., De Lena, M., Valagussa, P.: Combined chemotherapy(MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease. Cancer Treat. Rep. 61, 769 (1977)
Bonadonna, G., Fossati, V., De Lena, M.: MOPP vs MOPP plus ABVD in stage IV Hodgkin's disease. Proc. Am. Soc. Clin. Oncol. 19 (Abstr. C-227), 363 (1978)
Canellos, G. P., Young, R. C., De Vita, V. T.: Combination chemotherapy for advanced Hodgkin's disease in relapse following extensive radiotherapy. Clin. Pharmacol. Ther. 13, 750 (1972)
Case, D. C., Young, C. W., Lee, B. J., III: Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine, and vinblastine (ABVD). Cancer 39, 1382 (1977)
Clamon, G. H., Corder, M. P.: ABVD treatment of MOPP failures in Hodgkin's disease. A re-examination of goals of salvage therapy. Cancer Treat. Rep. 62, 363 (1978)
De Vita, V. T., Serpik, A. A., Carbone, P. P.: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann. Intern. Med. 73, 881 (1970)
De Vita, V. T., Canellos, G. P., Hubbard, S.: Chemotherapy of Hodgkin's disease with MOPP: A ten-year progress report. Proc. Am. Soc. Clin. Oncol. 17 (Abstr. C-131), 269 (1976)
Fisher, R. I., De Vita, V. T., Hubbard, S. H., Young, R. C.: Prolonged disease-free survival in Hodgkin's disease following re-induction with MOPP. Proc. Am. Soc. Clin. Oncol. 18, (Abstr. C-208) 318 (1977)
Goldman, J. M., Dawson, A. A.: Combination therapy for advanced Hodgkin's disease. 1975 II, 1224
Krikorian, J. G., Portlock, C. S., Rosenberg, S. A.: Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy. Cancer 41, 2107 (1978)
Kurnick, J. E., White, M., Ware, D. E., Robinson, W. A.: Bleomycin and CCNU in the combination chemotherapy of MOPP-resistant Hodgkin's disease. Cancer Chemother. Rep. 59, 1147 (1975)
Levi, J. A., Wiernik, P. H., Diggs, C. H.: Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin, and bleomycin. Med. Pediatr. Oncol. 3, 33 (1977)
Loh, K. K., Gamble, J. F., Shullemberger, C. C., Fuller, L. M.: Combination chemotherapy in MOPP-resistant Hodgkin's disease. Proc. Am. Soc. Clin. Oncol. 18 (Abstr. C-3), 267 (1977)
Lokich, J. J., Frei, E., III, Jaffe, N., Tullis, J.: New multiple agent chemotherapy (B-DOPA) for advanced Hodgkin's disease. Cancer 38, 667 (1976)
Porzig, K. J., Portlock, C. S., Robertson, A., Rosenberg, S. A.: Treatment of advanced Hodgkin's disease with B-CA Ve following MOPP failure. Cancer 41, 1670 (1978)
Santoro, A., Zucali, R., Volterrani, F., Bonadonna, G.: Combined chemotherapy-radiotherapy approach in stages IIB, IIIA, and IIIB Hodgkin's disease. Proc. Am. Ass. Cancer Res. 19 (Abstr. 859), 215 (1978)
Schwartz, D., Flamant, R., Lellouch, J.: L'essai thérapeutique chez l'homme. p. 230. Paris: Editions Médicales Flammarion 1970
Vicente, J., Cortés Funes, H.: ABVD for the treatment of advanced lymphomas. Proc. Am. Ass. Cancer Res. 17 (Abstr. 754), 189 (1976)
Vinciguerra, V., Coleman, M., Iarowski, C. I., Degnan, T. J., Silver, R. T.: A new combination chemotherapy for resistant Hodgkin's disease. JAMA 33, 237 (1977)
Warren, R. D., Bender, R. A., Norton, L., Young, R. C.: The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine. Am. J. Hematol. 4, 47 (1978)
Williams, S. D., Einhorn, L. H.: Combination chemotherapy with doxorubicin and lomustine. Treatment of refractory Hodgkin's disease. JAMA 283, 1659 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santoro, A., Bonadonna, G. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). Cancer Chemother. Pharmacol. 2, 101–105 (1979). https://doi.org/10.1007/BF00254081
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254081